CLINICAL_TRIALS
trial_result
· 2006-11-10
Clinical Trial Update: Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2. [NA]
Summary
A completed study investigating calcitonin gene-related peptide-induced headache in patients with familial hemiplegic migraine type 1 and 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Danish Headache Center | Conditions: Familial Hemiplegic Migraine | NA | Status: COMPLETED